Coya Therapeutics Inc. (NASDAQ: COYA)
$7.65
-0.0500 ( -0.65% ) 65.5K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$7.65
Previous close
$7.70
Volume
65.5K
Market cap
$116.75M
Day range
$7.51 - $7.78
52 week range
$3.21 - $10.69
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 8-k | 8K-related | 14 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 8-k | 8K-related | 15 | May 20, 2024 |
| 8-k | 8K-related | 12 | May 09, 2024 |
| 10-q | Quarterly Reports | 51 | May 09, 2024 |
| 8-k | 8K-related | 14 | May 08, 2024 |
| ars | Annual reports | 1 | Mar 28, 2024 |